· Журналы · Книги · О проекте ·Электронные версии книг издательства “Атмосфера” поступили в продажу Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru ИНТЕРНЕТ-МАГАЗИН    Атмосфера. Новости кардиологии 2022 / N 1 “Великолепная четверка”: эффективность и влияние каждого из 4 компонентов базовой терапии и своевременности их назначения на прогноз пациентов с хронической сердечной недостаточностью Ю.А. Карпов, С.Ю. Пушкарева, В.Н. Тхорикова References 1. Conrad N, Judge A, Tran J, Mohseni H, Hedgecott D, Crespillo AP, Allison M, Hemingway H, Cleland JG, McMurray JJV, Rahimi K. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. The Lancet 2018 Feb;391(10120):572-80. 2. The CAPACITY-COVID Collaborative Consortium and LEOSS Study Group. Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries. European Heart Journal 2022 Mar;43(11):1104-20. 3. Polyakov DS, Fomin IV, Belenkov YuN, Mareyev VYu, Ageyev FT, Artemyeva EG, Badin YuV, Bakulina EV, Vinogradova NG, Galyavich AS, Ionova TS, Kamalov GM, Kechedzhiyeva SG, Koziolova NA, Malenkova VYu, Malchikova SV, Mareyev YuV, Smirnova EA, Tarlovskaya EI, Shcherbinina EV, Yakushin SS. Chronic heart failure in the Russian federation: what has changed over 20 years of follow-up? Results of the EPOCH-CHF study. Kardiologiia 2021;61(4):4-14 (In Russian). 4. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Piepoli MF, Price S, Rosano GMC, Ruschitzka F, Skibelund AK; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal 2021 Sep;42(36):3599-726. 5. Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW. 2022 AHA/ACC/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022 May;145(18):e895-1032. 6. Tereshchenko SN, Galyavich AS, Uskach TM, Ageyev FT, Arutyunov GP, Begrambekova YuL, Belenkov YuN, Boytsov SA, Vasyuk YuA, Garganeyeva AA, Gendlin GE, Gilyarevskiy SR, Glezer MG, Gautier SV, Gupalo EM, Dovzhenko TV, Drapkina OM, Duplyakov DV, Zhirov IV, Zateyshchikov DA, Kobalava ZhD, Koziolova NA, Koroteyev AV, Libis RA, Lopatin YuM, Mareyev VYu, Mareev YuV, Matskeplishvili ST, Nasonova SN, Narusov OYu, Nedoshivin AO, Ovchinnikov AG, Orlova YaA, Perepech NB, Samko AN, Saidova MA, Safiullina AA, Sitnikova MYu, Skvortsov AA, Skibitskiy VV, Stukalova OV, Tarlovskaya EI, Tereshchenko AS, Chesnikova AI, Fomin IV, Shevchenko AO, Shaposhnik II, Sharia MA, Shlyakhto EV, Yavelov IS, Yakushin SS. 2020 clinical practice guidelines for chronic heart failure. Russian Journal of Cardiology 2020;25(11):311-74 (In Russian). 7. McMurray JJV, Solomon SD, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, Bělohlávek J, Böhm M, Chiang CE, Chopra VK, de Boer RA, Desai AS, Diez M, Drozdz J, Dukát A, Ge J, Howlett JG, Katova T, Kitakaze M, Ljungman CEA, Merkely B, Nicolau JC, O’Meara E, Petrie MC, Vinh PN, Schou M, Tereshchenko S, Verma S, Held C, DeMets DL, Docherty KF, Jhund PS, Bengtsson O, Sjöstrand M, Langkilde AM; DAPA-HF Trial Committees and Investigators. Dapagliflozin in patients with heart failure and reduced ejection fraction. The New England Journal of Medicine 2019 Nov;381(21):1995-2008. 8. Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, Januzzi J, Verma S, Tsutsui H, Brueckmann M, Jamal W, Kimura K, Schnee J, Zeller C, Cotton D, Bocchi E, Böhm M, Choi DJ, Chopra V, Chuquiure E, Giannetti N, Janssens S, Zhang J, Juanatey JRG, Kaul S, Brunner-La Rocca HP, Merkely B, Nicholls SJ, Perrone S, Pina I, Ponikowski P, Sattar N, Senni M, Seronde MF, Spinar J, Squire I, Taddei S, Wanner C, Zannad F; EMPEROR-Reduced Trial Investigators. Cardiovascular and renal outcomes with empagliflozin in heart failure. The New England Journal of Medicine 2020 Oct;383(15):1413-24. 9. Karpov YuA. Chronic heart failure: a new definition and novel treatment approaches. Atmosphere. Cardiology News 2020;4:30-40 (In Russian). 10. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. The New England Journal of Medicine 1999 Sep;341(10):709-17. 11. Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B; EMPHASIS-HF Study Group. Eplerenone in patients with systolic heart failure and mild symptoms. The New England Journal of Medicine 2011 Jan;364(1):11-21. 12. Swedberg K, Zannad F, McMurray JJV, Krum H, van Veldhuisen DJ, Shi H, Pitt JVB; EMPHASIS-HF Study Investigators. Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study. Journal of the American College of Cardiology 2012 May;59(18):1598-603. 13. Ministry of Health of the Russian Federation; Russian Cardiological Society; Russian Association of Cardiovascular Surgeons. Clinical recommendations. Acute coronary syndrome with ST-segment elevation. ICD 10: I20.0, I21.0, I21.1, I21.2, I21.3, I21.9, I22.0, I22.1, I22.8, I22.9, I24.8. Age group: adults. Year of approval: 2020. Moscow, 2020. 157 p. (In Russian). 14. Ministry of Health of the Russian Federation; Russian Society of Cardiology; Russian Association of Cardiovascular Surgeons. Clinical recommendations. Acute coronary syndrome with non-ST-segment elevation. ICD 10: I20.0, I21.0, I21.1, I21.2, I21.3, I21.4, I21.9, I22.0, I22.1, I22.8, I22.9, I24.8, I24.9. Year of approval: 2020. Moscow, 2020. 109 p. (In Russian). 15. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M; Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. The New England Journal of Medicine 2003 Apr;348(14):1309-21. 16. Carillo S, Zhang Y, Fay R, Angioi M, Vincent J, Sutradhor SC, Ahmed A, Pitt B, Zannad F. Heart failure with systolic dysfunction complicating acute myocardial infarction-differential outcomes but similar eplerenone efficacy by ST-segment or non-ST-segment elevation: a post-hoc substudy of the EPHESUS trial. Archives of Cardiovascular Diseases 2014 Mar;107(3):149-57. 17. Tromp J, Ouwerkerk W, van Veldhuisen D, Hillege HL, Richards AM, van der Meer P, Anand IS, Lam CSP, Voors AA. A systematic review and network meta-analysis of pharmacological treatment of heart failure with reduced ejection fraction. JACC. Heart Failure 2022 Feb;10(2):73-84.    [ Содержание выпуска N 1 | Выпуски журнала | Список журналов ]